Godavari Drugs Ltd

₹ 120 -2.94%

23 Oct - close price

About

Incorporated in 1987, Godavari Drugs Ltd manufactures and sale of Active Pharmaceutical Ingredients and their intermediates^[1]

Key Points

Business Overview:^[1]
GDL is in the business of manufacturing of APls, intermediates and fine chemicals as per the requirements of the global life science industry. It also explores Loan licenses and Contract Manufacturing tie-ups with reputed multinational co. for Narcotic Products, API and drug intermediates, to partners who have
such requirements.

Website BSE

Market Cap ₹ 132 Cr.
Current Price ₹ 120
High / Low ₹ 144 / 69.7
Stock P/E 33.8
Book Value ₹ 74.8
Dividend Yield 0.00 %
ROCE 6.55 %
ROE 6.14 %
Face Value ₹ 10.0

Add ratio to table

Edit ratios

Pros

Cons

Though the company is reporting repeated profits, it is not paying out dividend
The company has delivered a poor sales growth of -2.91% over past five years.
Company has a low return on equity of 9.95% over last 3 years.
Company might be capitalizing the interest cost
Company has high debtors of 150 days.
Promoter holding has decreased over last 3 years: -12.9%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Figures in Rs. Crores

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	35.42	39.54	43.11	38.64	32.21	26.09	29.55	25.50	23.81	26.65	22.18	33.16	27.96
	33.17	36.47	39.59	34.17	28.98	23.19	26.97	22.39	20.91	24.65	19.71	30.22	25.44
Operating Profit	2.25	3.07	3.52	4.47	3.23	2.90	2.58	3.11	2.90	2.00	2.47	2.94	2.52
OPM %	6.35%	7.76%	8.17%	11.57%	10.03%	11.12%	8.73%	12.20%	12.18%	7.50%	11.14%	8.87%	9.01%
	0.45	0.00	-0.01	0.08	0.77	0.01	0.10	0.11	0.01	0.64	0.27	0.25	0.15
Interest	1.11	1.30	1.27	1.23	1.44	1.08	1.11	1.11	1.00	0.91	1.11	0.96	0.90
Depreciation	0.47	0.49	0.50	0.53	0.55	0.58	0.64	0.67	0.60	0.60	0.61	0.61	0.59
Profit before tax	1.12	1.28	1.74	2.79	2.01	1.25	0.93	1.44	1.31	1.13	1.02	1.62	1.18
Tax %	27.68%	32.81%	29.89%	4.66%	18.91%	12.80%	16.13%	38.19%	19.85%	10.62%	25.49%	20.37%	5.93%
	0.81	0.86	1.22	2.66	1.63	1.09	0.77	0.89	1.04	1.00	0.76	1.29	1.11
EPS in Rs	1.08	1.14	1.62	3.53	2.16	1.45	1.02	1.18	1.38	1.33	1.01	1.27	1.10
Raw PDF

Profit & Loss

Figures in Rs. Crores

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	55	71	76	64	84	96	123	161	160	157	113	106	110
	49	67	70	60	78	90	113	150	150	143	102	95	100
Operating Profit	6	4	5	4	5	6	10	11	10	13	12	10	10
OPM %	11%	6%	7%	6%	7%	6%	8%	7%	6%	8%	10%	10%	9%
	0	0	1	1	0	0	0	0	1	1	1	1	1
Interest	1	2	3	2	3	3	3	3	4	5	5	4	4
Depreciation	1	1	1	1	1	1	1	2	2	2	2	2	2
Profit before tax	5	2	3	1	2	2	6	7	5	7	6	5	5
Tax %	23%	38%	33%	37%	31%	13%	28%	25%	23%	20%	22%	19%
	4	1	2	1	1	2	4	5	4	6	4	4	4
EPS in Rs	4.85	1.79	2.40	1.10	1.61	2.66	5.48	6.97	5.03	7.37	5.82	4.04	4.71
Dividend Payout %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Compounded Sales Growth
10 Years:	4%
5 Years:	-3%
3 Years:	-13%
TTM:	5%

Compounded Profit Growth
10 Years:	10%
5 Years:	-2%
3 Years:	0%
TTM:	3%

Stock Price CAGR
10 Years:	10%
5 Years:	13%
3 Years:	11%
1 Year:	39%

Return on Equity
10 Years:	11%
5 Years:	12%
3 Years:	10%
Last Year:	6%

Balance Sheet

Figures in Rs. Crores

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	8	8	8	8	8	8	8	8	8	8	8	10
Reserves	6	7	9	10	11	13	17	22	26	31	36	66
	8	16	16	19	22	28	30	23	36	58	64	82
	13	21	24	27	33	36	36	49	52	38	35	43
Total Liabilities	35	51	56	63	74	84	91	101	121	135	143	200
	7	9	13	15	15	14	22	26	25	27	33	30
CWIP	0	1	0	1	2	9	1	0	9	18	30	57
Investments	0	0	0	0	0	0	0	0	0	0	0	0
	27	41	43	47	57	61	68	75	87	90	81	114
Total Assets	35	51	56	63	74	84	91	101	121	135	143	200

Cash Flows

Figures in Rs. Crores

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	-6	-5	5	4	4	6	1	11	13	18	11	1
	-0	-2	-3	-3	-2	-7	-1	-5	-9	-13	-20	-26
	6	7	-2	-0	-1	0	0	-6	-4	-6	8	37
Net Cash Flow	0	0	0	1	-0	-0	0	1	1	-0	-0	12
Free Cash Flow	-6	-7	1	0	1	-1	-0	6	4	5	-9	-26
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	-101%	-101%	108%	109%	73%	108%	26%	110%	143%	146%	105%	19%

Ratios

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	87	126	117	152	148	137	134	126	132	138	136	150
Inventory Days	84	67	70	100	93	84	55	28	57	62	125	217
Days Payable	79	108	124	171	171	144	112	121	132	96	128	163
Cash Conversion Cycle	92	85	63	81	70	78	78	33	58	105	133	204
Working Capital Days	63	44	40	47	38	31	46	32	23	9	11	42
ROCE %	32%	16%	17%	11%	12%	12%	18%	18%	14%	14%	10%	7%

Insights

In beta

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

Agro/Industrial Waste Consumption
Tons

x,xxx.xx	x,xxx.xx	x,xxx.xx	x,xxx.xx	x,xxx.xx	x,xxx.xx	x,xxx.xx	x,xxx.xx	x,xxx.xx	x,xxx.xx
x,xxx.xx	x,xxx.xx	x,xxx.xx	x,xxx.xx	x,xxx.xx	x,xxx.xx	x,xxx.xx	x,xxx.xx	x,xxx.xx	x,xxx.xx
xx.xx	xx.xx	xxx.xx	xx.xx	xxx.xx	xxx.xx	xx.xx	xxx.xx	xx.xx	xxx.xx
x,xxx.xx	x,xxx.xx	x,xxx.xx	x,xxx.xx	x,xxx.xx		xx,xxx.xx	x,xxx.xx	x,xxx.xx	x,xxx.xx
xx	xx	xxx	xxx	xxx		xxx	xxx	xxx	xxx
xx.xx	xx.xx	xx.xx	xx.xx	xx.xx		xx.xx	xx.xx	xx.xx	xx.xx

Please log in to see hidden values.

Electricity Consumption
'000 KWH

Export Sales (FOB basis)
Rs. Lakhs

Foreign Exchange Outgo on Raw Material Imports (CIF basis)
Rs. Lakhs

Number of Permanent Employees
Nos.

R&D Expenditure (Recurring)
Rs. Lakhs

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
	53.16%	53.16%	53.16%	52.63%	52.63%	52.63%	52.63%	52.61%	52.61%	40.23%	40.23%	40.23%
	0.50%	0.50%	0.50%	0.50%	0.50%	0.50%	0.50%	0.50%	0.50%	2.47%	2.74%	2.79%
	46.35%	46.34%	46.34%	46.87%	46.87%	46.87%	46.87%	46.90%	46.89%	57.31%	57.04%	56.98%
No. of Shareholders	6,894	7,005	7,044	7,709	7,915	7,881	7,828	7,720	7,483	7,300	6,722	6,749

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	Sep 2026
	49.91%	54.00%	54.00%	55.86%	55.86%	56.36%	53.12%	53.16%	52.63%	40.23%	40.23%
	0.00%	0.50%	0.50%	0.50%	0.50%	0.50%	0.50%	0.50%	0.50%	2.47%	2.79%
	50.09%	45.51%	45.51%	43.65%	43.65%	43.15%	46.39%	46.34%	46.87%	57.31%	56.98%
No. of Shareholders	4,285	4,083	3,980	3,928	4,136	6,034	6,555	7,005	7,881	7,300	6,749

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Godavari Drugs Ltd

Godavari Drugs Ltd

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flows

Ratios

Insights

Shareholding Pattern

Documents

Announcements

Annual reports

Credit ratings